Exposure core
曝光核心
基本信息
- 批准号:8535762
- 负责人:
- 金额:$ 12.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAcidsAcute Lung InjuryAerosolsAirAlteplaseAnesthesia proceduresAnestheticsAnimal ExperimentsAnimal HousingAnimalsAnticoagulantsAntioxidantsAppearanceAreaAutopsyBiochemicalBlood capillariesBody FluidsBreathingCaliberCertificationChemical ModelsChemicalsChlorineCollaborationsColorColoradoComputersConsciousCross-Over StudiesDNA DamageDataDistressEdemaEnsureEnvironmental air flowEvaluationEventExposure toFree RadicalsGasesHeadHealthHourHuman ResourcesInflammationInjuryIntervention StudiesLaboratoriesLaboratory ProceduresLiquid substanceLungMaintenanceMechlorethamineMedicalMethodsModelingMonitorMustardMustard GasNew AgentsNoseOperative Surgical ProceduresPerfusionPeripheralPharmaceutical PreparationsPlasminogen ActivatorPoisonPreparationProceduresProcessProtocols documentationPublicationsPulmonary function testsPulse OximetryQualifyingQuality ControlRattusRecordsRegulationReportingResearch PersonnelResourcesRodentSafetySamplingSiteSkinStethoscopesStructure of parenchyma of lungSupervisionSystemTechniquesTestingTherapeutic InterventionThrombolytic TherapyTimeTissue ProcurementsToxic effectTravelUniversitiesVertebratesVesicantsWeightWhole Body PlethysmographyWork of BreathingWritinganimal carebasecapillarychlorine gascomputerized data processingdata modelingfollower of religion Jewishhealth recordin vivointerestlung injurymembernovel therapeuticsprogramsprotective effectresearch studysilibininsound
项目摘要
The Exposure Core consists of an AinA/ay (Lung) Exposure Core based in Denver at National Jewish Health and a Skin Exposure Core based at University of Colorado Denver on the medical campus. The Ainway (Lung) Exposure Core consists of an offsite exposure facility at USAMRICD (Aberdeen, MD) subcontracted for exposure of rats to SM (described herein) supervised by our collaborator Dana Anderson, and Denver (National Jewish Health)-based exposure facilities for ain/vay exposures to half-mustard (2-chloroethyl
ethylsulfide, CEES; nose-only system) and chlorine (whole body). The former provides an ethanolic aerosol (0.6 micron mass median diameter) by nose-only delivery to anesthetized rats in an established model. The latter provides chlorine gas in dry dilution air by whole body exposure to conscious rats in a more recently constructed system that is functioning and providing results similar to those reported by others with similar
levels of exposure. Verification of exposure levels in the chlorine system is based on the 'sulfamic acid trap' method previously described Rando and colleagues. Processing of lung tissue and body fluids from rats exposed to these three toxic inhaled gases is illustrated in schematic diagram. For studies requiring airway instillation of drugs (eg tPA) with SM exposure, a small group of investigators (1) and technicians (2) from
National Jewish will travel to USAMRICD 2-4 times annually to assist in these more labor-intensive studies.
Pulmonary function testing (flexiVent) is available nearby to CEES and chlorine exposure systems in Denver, and also at the SM facility in Aberdeen (Buxco whole body plethysmography). The latter is described herein and the former is in Project 1. The Ainway Exposure Core is heavily used mainly by Projects 1 and 2. The Skin Exposure Core during the first cycle established an in vivo exposure system for CEES that can cause reproducible microvesication, DNA damage, inflammation and edema, and more recentiy has developed a nitrogen mustard exposure system that results in all of these events but with much more marked potency. The Core includes interactive studies will all 3 Projects.
暴露核心由丹佛的AINA/AY(肺)暴露核心组成,以及位于科罗拉多州丹佛分校的医学院丹佛分校的皮肤暴露核心。 Ainway(肺)暴露核心包括在Usamricd(马里兰州阿伯丁市)的异地暴露设施组成,分包了将大鼠暴露于SM(此处描述的)由我们的合作者Dana Anderson和Denver(National Jewish Health)(国家犹太人健康)基于AIN/VAY-MUSTOURAS的曝光设施,以实现AIN/VAY-MUSTORES的暴露设施
乙基硫化物,CEES;仅鼻子系统)和氯(全身)。前者通过在既定模型中向麻醉大鼠递送到麻醉大鼠的乙醇气溶胶(0.6微米质量中值直径)。后者通过全身暴露于最近构造的系统中的有意识大鼠在干稀释空气中提供氯气,该系统正常运行,并提供了与其他人报告的结果相似的结果
暴露水平。氯系统中暴露水平的验证基于先前描述的Rando及其同事的“磺酸陷阱”方法。示意图中说明了暴露于这三种有毒吸入气体的大鼠的肺组织和体液的处理。对于需要气道滴注药物(例如TPA)的研究,一小部分研究人员(1)和技术人员(2)
国家犹太人每年将2-4次前往USAMRICD,以协助这些更加劳动密集型研究。
在丹佛的CEES和氯暴露系统附近以及在Aberdeen的SM设施(Buxco全身ProplesyMmography)附近可用肺功能测试(Flexivent)。后者在本文中描述了后者,前者在项目1中。AINWay暴露核心主要由项目1和2进行大量使用。在第一个周期中,皮肤暴露核心建立了CEES的体内暴露系统,该系统可能会导致可重复性的微神经,DNA损伤,炎症,炎症和湿气,以及更多的氮气曝光系统,这些事件都在这些事件中得到了更多的影响。核心包括互动研究将所有3个项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carl W White其他文献
CXCL17 induces activation of human mast cells via MRGPRX2
CXCL17 通过 MRGPRX2 诱导人类肥大细胞激活
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Jie Ding;Christina Hillig;Carl W White;Nithya A Fernandopulle;Holly Anderton;Johannes S Kern;Michael P. Menden;Graham A Mackay - 通讯作者:
Graham A Mackay
3 ROS : reactive oxygen species RT-qPCR : reverse transcription quantitative PCR SM : sulfur mustard SpO 2 : peripheral oxygen saturation tPA : tissue plasminogen activator
3 ROS : 活性氧 RT-qPCR : 逆转录定量 PCR SM : 硫芥 SpO 2 : 外周血氧饱和度 tPA : 组织纤溶酶原激活剂
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Heidi J. Nick;Carly A Johnson;Amber R. Stewart;Sarah Christeson;A. Leslie;Bloomquist;Amanda S. Appel;A. Donkor;L. Veress;B. Logue;E. Preston;Bratcher;Carl W White - 通讯作者:
Carl W White
Carl W White的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carl W White', 18)}}的其他基金
New Developments in Chemical Countermeasures: CounterACT 2018
化学对抗新进展:CounterACT 2018
- 批准号:
9490163 - 财政年份:2016
- 资助金额:
$ 12.46万 - 项目类别:
Hypoxic-Inducible Factors in Neonatal Pulmonary Hypertension
新生儿肺动脉高压的缺氧诱发因素
- 批准号:
8214146 - 财政年份:2011
- 资助金额:
$ 12.46万 - 项目类别:
CRITICAL TARGETS IN HYPEROXIC MITOCHONDRIAL INJURY
高氧线粒体损伤的关键目标
- 批准号:
7716163 - 财政年份:2008
- 资助金额:
$ 12.46万 - 项目类别:
Novel antioxidant therapeutics for sulfur mustard toxicity (U54)
针对硫芥毒性的新型抗氧化疗法 (U54)
- 批准号:
7294907 - 财政年份:2006
- 资助金额:
$ 12.46万 - 项目类别:
相似国自然基金
基于“肠肺轴”探讨迷迭香酸通过调控肠道菌群对LPS致急性肺损伤小鼠的保护作用及其机制
- 批准号:32360897
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Omega-3多不饱和脂肪酸通过抑制TRPA1离子通道减轻臭氧急性肺功能损伤的机制研究
- 批准号:82203985
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
Omega-3多不饱和脂肪酸通过抑制TRPA1离子通道减轻臭氧急性肺功能损伤的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
低分子量透明质酸诱导肺微血管内皮细胞自噬介导脓毒症急性肺损伤的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
线粒体柠檬酸堆积在急性肺损伤中的作用及其机制研究
- 批准号:82170096
- 批准年份:2021
- 资助金额:57.00 万元
- 项目类别:面上项目
相似海外基金
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis
磷酸酶和张力蛋白同源物 PTEN 在多种微生物败血症中的作用
- 批准号:
10005956 - 财政年份:2014
- 资助金额:
$ 12.46万 - 项目类别:
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis
磷酸酶和张力蛋白同源物 PTEN 在多种微生物败血症中的作用
- 批准号:
10418725 - 财政年份:2014
- 资助金额:
$ 12.46万 - 项目类别:
Phosphatase and tensin homolog PTEN actions in polymicrobial sepsis
磷酸酶和张力蛋白同源物 PTEN 在多种微生物败血症中的作用
- 批准号:
10201714 - 财政年份:2014
- 资助金额:
$ 12.46万 - 项目类别:
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis
瓜氨酸预防或减轻严重脓毒症的急性肺损伤
- 批准号:
8610942 - 财政年份:2012
- 资助金额:
$ 12.46万 - 项目类别:
Citrulline to Prevent or Mitigate Acute Lung Injury in Severe Sepsis
瓜氨酸预防或减轻严重脓毒症的急性肺损伤
- 批准号:
8240853 - 财政年份:2012
- 资助金额:
$ 12.46万 - 项目类别: